Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP885787.RA6qn32kLOXvMJ2TvSMvy-ab6Wj3GdlRGUZCFRZMaJFlA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP885787.RA6qn32kLOXvMJ2TvSMvy-ab6Wj3GdlRGUZCFRZMaJFlA130_assertion type Assertion NP885787.RA6qn32kLOXvMJ2TvSMvy-ab6Wj3GdlRGUZCFRZMaJFlA130_head.
- NP885787.RA6qn32kLOXvMJ2TvSMvy-ab6Wj3GdlRGUZCFRZMaJFlA130_assertion description "[This led us to question whether long CDR-H3s and high levels of somatic mutation (SM) are a preferred feature of anti-HIV bNt MAbs, or if other adaptive immune responses elicit them in general.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885787.RA6qn32kLOXvMJ2TvSMvy-ab6Wj3GdlRGUZCFRZMaJFlA130_provenance.
- NP885787.RA6qn32kLOXvMJ2TvSMvy-ab6Wj3GdlRGUZCFRZMaJFlA130_assertion evidence source_evidence_literature NP885787.RA6qn32kLOXvMJ2TvSMvy-ab6Wj3GdlRGUZCFRZMaJFlA130_provenance.
- NP885787.RA6qn32kLOXvMJ2TvSMvy-ab6Wj3GdlRGUZCFRZMaJFlA130_assertion SIO_000772 21479208 NP885787.RA6qn32kLOXvMJ2TvSMvy-ab6Wj3GdlRGUZCFRZMaJFlA130_provenance.
- NP885787.RA6qn32kLOXvMJ2TvSMvy-ab6Wj3GdlRGUZCFRZMaJFlA130_assertion wasDerivedFrom befree-2016 NP885787.RA6qn32kLOXvMJ2TvSMvy-ab6Wj3GdlRGUZCFRZMaJFlA130_provenance.
- NP885787.RA6qn32kLOXvMJ2TvSMvy-ab6Wj3GdlRGUZCFRZMaJFlA130_assertion wasGeneratedBy ECO_0000203 NP885787.RA6qn32kLOXvMJ2TvSMvy-ab6Wj3GdlRGUZCFRZMaJFlA130_provenance.